Jump to content
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Record is Archived

    This article is now archived and is closed to further replies.

    Scott Adams
    Scott Adams

    New Type of Inflammatory Bowel Disease Discovered in Children With Developmental Disorders

    Reviewed and edited by a celiac disease expert.

    Am J Gastroenterol 2000;95:2154-2156,2285-2295.

    Celiac.com Sponsor (A12):
    Celiac.com 10/14/2000 - According to new research done by Dr. Andrew J. Wakefield, of the Royal Free and University College Medical School, in London (published in the September issue of the American Journal of Gastroenterology) children with developmental disorders seem to be at risk of developing a unique type of inflammatory bowel disease (IBD). This newly discovered type lacks the typical features seen in Crohns disease and ulcerative colitis.

    The researchers studied 60 children with developmental disorders (50 had autism, five had Aspergers syndrome, two had disintegrative disorder, one had attention deficit hyperactivity disorder, one had schizophrenia and one had dyslexia.) whose ages ranged from 3 to 16 years old to compare the clinical and histologic features against 37 developmentally normal controls who underwent evaluation for possible IBD.

    According to Dr. Wakefield and colleagues The combination of ileocolonic lymphoid nodular hyperplasia and colitis in children with developmental disorders distinguished them from developmentally normal children with similar symptoms (including abdominal pain and constipation) in whom lymphoid nodular hyperplasia and histopathological change were uncommon. They emphasize that their finding are consistent with those of other recent case studies, and that in their study inflammatory changes were detected in the upper gastrointestinal tract that were unique in children with autism and IBD, compared with developmentally normal children with IBD.

    Further, there is accumulating evidence of a specific type of enterocolitis in autism that makes it tempting to suggest that a gut-brain interaction is involved in the pathogenesis of what many researchers are now calling autistic enterocolitis. The detection of opioid peptides of dietary origin in the urine of some of the affected children further supports this theory. The team emphasizes that further studies and more evidence is needed to establish a direct link between an inflamed gut and the brain in those with autism.



    User Feedback

    Recommended Comments

    There are no comments to display.



    Guest
    This is now closed for further comments

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Scott Adams

    Scott Adams was diagnosed with celiac disease in 1994, and, due to the nearly total lack of information available at that time, was forced to become an expert on the disease in order to recover. In 1995 he launched the site that later became Celiac.com to help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives.  He is co-author of the book Cereal Killers, and founder and publisher of the (formerly paper) newsletter Journal of Gluten Sensitivity. In 1998 he founded The Gluten-Free Mall which he sold in 2014. Celiac.com does not sell any products, and is 100% advertiser supported.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Jefferson Adams
    Antibiotics Put Children at Risk for Inflammatory Bowel Disease
    Celiac.com 11/28/2012 - A team of researchers recently set out to determine whether childhood antianaerobic antibiotic exposure is associated with the development of inflammatory bowel disease (IBD). Their findings show that children who are treated with antianaerobic antibiotics face a significantly higher risk of developing IBD.
    The team included Matthew P. Kronman, MD, MSCE, Theoklis E. Zaoutis, MD, MSCE, Kevin Haynes, PharmD, MSCE, Rui Feng, PhD, and Susan E. Coffin, MD, MPH.They are affiliated variously with the Division of Infectious Diseases, Seattle Children’s Hospital at the University of Washington in Seattle, Washington, the Division of Infectious Diseases at The Children’s Hospital of Philadelphia, and the Department of Biostatistics and Epidemiology, the Center for Cli...


  • Recent Activity

    1. - Scott Adams replied to Rejoicephd's topic in Coping with Celiac Disease
      7

      Draft gluten-free ciders… can they be trusted ?

    2. - Rejoicephd replied to Rejoicephd's topic in Coping with Celiac Disease
      7

      Draft gluten-free ciders… can they be trusted ?

    3. - Inkie replied to Inkie's topic in Gluten-Free Foods, Products, Shopping & Medications
      2

      Tea Bags and Gluten

    4. - Scott Adams replied to Inkie's topic in Gluten-Free Foods, Products, Shopping & Medications
      2

      Tea Bags and Gluten

    5. - Scott Adams replied to deanna1ynne's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      1

      Inconclusive results


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      131,682
    • Most Online (within 30 mins)
      7,748

    Amber1rose
    Newest Member
    Amber1rose
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      121.4k
    • Total Posts
      1m

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • Julie 911
      7
    • Xravith
    • Inkie
      5
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...

Important Information

NOTICE: This site places This site places cookies on your device (Cookie settings). on your device. Continued use is acceptance of our Terms of Use, and Privacy Policy.